Psilocybin Tied to Lower Inflammation in Parkinson's Trial

(MedPage Today) -- Markers of systemic inflammation and mitochondrial stress were reduced after psilocybin therapy in Parkinson's disease patients with mood dysfunction, a small nonrandomized trial showed. Relative to baseline, an inflammatory...